EpiVax Launches AI-Enhanced Models for Immunogenicity Prediction
<p>PROVIDENCE, R.I., Sept. 2, 2026 /PRNewswire/ -- EpiVax, Inc. is pleased to announce the release of AI-enabled enhancements to ISPRI™, its proprietary in silico platform for assessing the immunogenicity risk of biotherapeutics. The release introduces an updated JanusMatrix™ model, a...</p>
Read original article ↗
Related Articles
Helfie AI Appoints John Rego as Chief Financial Officer
Veteran CFO with more than $10 billion raised across six public and private companies joins Helfie AI to lead financial
Helfie AI nomme John Rego au poste de directeur financier
Ce directeur financier chevronné, qui a déjà levé plus de 10 milliards de dollars au sein de six sociétés cotées et non
Helfie AI ernennt John Rego zum Chief Financial Officer
Erfahrener CFO, der bei sechs börsennotierten und privaten Unternehmen insgesamt mehr als 10 Milliarden US-Dollar eingew
Helfie AI nombra a John Rego como director financiero
Director financiero veterano con más de 10.000 millones de dólares recaudados en seis empresas públicas y privadas se un